Glaxosmithkline Pharmaceuticals reports around 5-fold jump in Q2 consolidated net profit

23 Oct 2019 Evaluate

Glaxosmithkline Pharmaceuticals has reported results for second quarter ended September 30, 2019.

The company has reported around 5-fold jump in its net profit at Rs 502.79 crore for the quarter under review as compared to Rs 100.77 crore for the same quarter in the previous year. Total income of the company increased by 8.01% at Rs 897.71 crore for Q2FY20 as compared Rs 831.13 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported around 5-fold jump in its net profit at Rs 502.75 crore for the quarter under review as compared to Rs 100.83 crore for the same quarter in the previous year. Total income of the company increased by 8.01% at Rs 897.90 crore for Q2FY20 as compared Rs 831.32 crore for the corresponding quarter previous year.


Glaxosmithkline Phar Share Price

2543.10 33.80 (1.35%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×